Remember the controversy that the United States Preventive Services Task Force (USPSTF) stirred up 3 years ago with its then latest recommendations on screening for breast cancer ?  Remember the prospective cohort study published in the Annals of Internal Medicine last October in which the authors concluded that annual mammograms increased the risk of false positive interpretations?  Remember the retrospective study published earlier this past April in the Annals of Internal Medicine in which the authors concluded that breast cancer was overdiagnosed in 15-25% of women who were screened?